Haitham Abdulla
Glucagon-like peptide 1 infusions overcome anabolic resistance to feeding in older human muscle
Abdulla, Haitham; Phillips, Bethan E.; Wilkinson, Daniel J.; Limb, Marie; Jandova, Tereza; Bass, Joseph J.; Rankin, Debbie; Cegielski, Jessica; Sayda, Mariwan; Crossland, Hannah; Williams, John P.; Smith, Kenneth; Idris, Iskandar; Atherton, Philip J.
Authors
Bethan E. Phillips
DANIEL WILKINSON DANIEL.WILKINSON@NOTTINGHAM.AC.UK
Principal Research Fellow
Marie Limb
Tereza Jandova
JOSEPH BASS Joseph.Bass@nottingham.ac.uk
Assistant Professor (Physiology and Endocrinology)
Debbie Rankin
Jessica Cegielski
Mariwan Sayda
HANNAH CROSSLAND Hannah.Crossland1@nottingham.ac.uk
Research Fellow
JOHN WILLIAMS john.williams7@nottingham.ac.uk
Clinical Associate Professor
KENNETH SMITH KEN.SMITH@NOTTINGHAM.AC.UK
Professor of Metabolic Mass Spectrometry
ISKANDAR IDRIS Iskandar.Idris@nottingham.ac.uk
Professor of Diabetes and Metabolic Medicine
PHILIP ATHERTON philip.atherton@nottingham.ac.uk
Professor of Clinical, metabolic & Molecular Physiology
Abstract
© 2020 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd Background: Despite its known insulin-independent effects, glucagon-like peptide-1 (GLP-1) role in muscle protein turnover has not been explored under fed-state conditions or in the context of older age, when declines in insulin sensitivity and protein anabolism, as well as losses of muscle mass and function, occur. Methods: Eight older-aged men (71±1year, mean±SEM) were studied in a crossover trial. Baseline measures were taken over 3hr, prior to a 3hr postprandial insulin (~30mIUml−1) and glucose (7–7.5mM) clamp, alongside I.V. infusions of octreotide and Vamin 14 (±infusions of GLP-1). Four muscle biopsies were taken, and muscle protein turnover was quantified via incorporation of 13C6 phenylalanine and arteriovenous balance kinetics, using mass spectrometry. Leg macro- and microvascular flow was assessed via ultrasound and anabolic signalling by immunoblotting. GLP-1 and insulin were measured by ELISA. Results: GLP-1 augmented muscle protein synthesis (MPS; fasted: 0.058±0.004%hr−1 vs. postprandial: 0.102±0.005%hr−1, p
Citation
Abdulla, H., Phillips, B. E., Wilkinson, D. J., Limb, M., Jandova, T., Bass, J. J., …Atherton, P. J. (2020). Glucagon-like peptide 1 infusions overcome anabolic resistance to feeding in older human muscle. Aging Cell, 19(9), Article e13202. https://doi.org/10.1111/acel.13202
Journal Article Type | Article |
---|---|
Acceptance Date | Jul 3, 2020 |
Online Publication Date | Aug 3, 2020 |
Publication Date | Aug 3, 2020 |
Deposit Date | Aug 14, 2020 |
Publicly Available Date | Aug 14, 2020 |
Journal | Aging Cell |
Print ISSN | 1474-9718 |
Electronic ISSN | 1474-9726 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 19 |
Issue | 9 |
Article Number | e13202 |
DOI | https://doi.org/10.1111/acel.13202 |
Keywords | Glucagon‐like peptide 1 |
Public URL | https://nottingham-repository.worktribe.com/output/4830706 |
Publisher URL | https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13202 |
Files
Glucagon‐like peptide 1 infusions overcome anabolic resistance to feeding in older human muscle
(740 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: digital-library-support@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search